title: Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-alpha.
abstract: Accumulating evidence has suggested that cellular production of superoxide acts as an intracellular messenger to regulate gene expression and modulate cellular activities. In this report, we set out to investigate the role of active H-ras-mediated superoxide production on tumor cell malignancy in a SV-40 transformed human lung WI-38 VA-13 cell line. Stable transfection and expression of constitutively active mutant V12-H-ras (V12-H-ras) dramatically increased intracellular production of superoxide. The expression of V12-H-ras significantly enhanced cell proliferation, migration and resistance to TNF-alpha treatment compared to that of parental and vector control cells, while expression of wild type H-ras (WT-H-ras) only had modest effects. Upon scavenging by superoxide dismutase and other molecules that decrease the intracellular level of active H-ras mediated superoxide production, cell proliferation, migration and resistance to TNF-alpha were significantly reduced. Furthermore, we demonstrated that the activation of membrane NADPH oxidase activity by expression of active H-ras contributed to the intracellular superoxide production. The causal relationship between membrane superoxide production and increased cell proliferation, migration, and resistance to TNF-alpha by the expression of active H-ras, has provided direct evidence to demonstrate that superoxide acts as an intracellular messenger to cascade ras oncogenic signal relay and to modulate tumor malignant activity.
authors: Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, Kentucky KY 40292, USA.
authors: R
authors: R
authors: Liu
authors: B
authors: B
authors: Li
authors: M
authors: M
authors: Qiu
mesh_terms: D000098:Acetophenones / Q000494:pharmacology; D000493:Allopurinol / Q000494:pharmacology; D002455:Cell Division; D002461:Cell Line, Transformed; D002465:Cell Movement; D004351:Drug Resistance; D004789:Enzyme Activation; D011905:Genes, ras; D019833:Genistein / Q000494:pharmacology; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology*; D008565:Membrane Proteins / Q000378:metabolism; D008954:Models, Biological; D019255:NADPH Oxidases / Q000378:metabolism; D009861:Onium Compounds / Q000494:pharmacology; D010117:Oxypurinol / Q000494:pharmacology; D047428:Protein Kinase Inhibitors; D012402:Rotenone / Q000494:pharmacology; D013481:Superoxides / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D000098:Acetophenones; D008565:Membrane Proteins; D009861:Onium Compounds; D047428:Protein Kinase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D012402:Rotenone; D013481:Superoxides; D000493:Allopurinol; C007517:diphenyleneiodonium; C056165:acetovanillone; D019833:Genistein; D019255:NADPH Oxidases; D010117:Oxypurinol